UnitedHealth gets FTC approval for DaVita deal - Forbes
June 19 (Reuters) - UnitedHealth Group Inc UNH.N has won Federal Trade Commission approval for its $4 billion buyout of the primary and urgent care unit of DaVita Inc DVA.N, Forbes reported on Wednesday.
After the deal closes, UnitedHealth's Optum, the unit which houses its pharmacy benefits business, will gain access to a large network of nearly 300 medical clinics that treat more than 1.7 million patients annually.
(Reporting by Saumya Sibi Joseph in Bengaluru; Editing by Arun Koyyur)
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.